QBDOTW: A 50-year-old obese female patient

MedSmarter Question Break Down of the Week - Micro - 07/07/2021

QBDOTW: A 50-year-old Obese Female Patient w/ Diabetes Mellitus

Welcome to MedSmarter’s USMLE Style Question Break Down of the Week.  For those preparing for the USMLE Step 1, this week we break down a high-yield Microbiology question.  As always you want to begin with reading the last sentence of the vignette first to get an understanding of what the question is asking for.

Question Break Down of the Week:

A 50-year-old obese female with poorly controlled non-insulin-dependent diabetes mellitus presents with fever to 39.4° C (102.9° F), jaundice, hypotension, and acute onset of right upper quadrant pain. Abdominal imaging shows multiple gallstones and cholecystitis. Urgent cholecystectomy is performed, and subsequent gall bladder fluid and blood cultures grow aerobic, non-lactose-fermenting, oxidase-positive, gram-negative rods. Blood tests show:

Hematocrit: 25%
WBC count: 15,300/mm3
Platelet count: 80,000/mm3
International Normalized Ratio: 3.2
D-dimer: 8200 ng/mL
Fibrinogen levels: low

Microscopic inspection of peripheral blood smear shows schistocytes and multiple helmet cells. Clinically, there is no evidence of active bleeding. What is the most appropriate treatment for this patients’ coagulopathy?

A)  Fresh frozen plasma
B)  Vancomycin
C)  Amoxicillin
D)  Aztreonam
E)  Vitamin K

The correct answer is D. This patient has Charcot’s triad (fever, jaundice, right upper quadrant pain) paired with leukocytosis, along with low blood pressure, giving us a clear clinical picture of cholecystitis. On top of that, he has Pseudomonas aeruginosa (aerobic, non-lactose-fermenting, oxidase-positive, gram-negative rods) sepsis and disseminated intravascular coagulation (DIC). Gram-negative rod sepsis is the obvious cause of this patient’s DIC, and antipseudomonal coverage with aztreonam is most appropriate. Aztreonam is a β-lactamase-resistant monobactam that interferes with cell wall biosynthesis by binding to penicillin-binding protein 3. Aztreonam is a potent antipseudomonal agent indicated for pseudomonal sepsis. Aztreonam has low bioavailability when given orally, so it is either IV or nebulized.

Did you think the answer was different?

Did you think that the correct answer choice was other than D?  You can view this video for a deeper discussion of why A, B, C, and E were not the correct answer choices.

Learn to correctly answer basic science knowledge questions and prepare to take your USMLE Step 1 exam.  The MedSmarter roadmap will make your journey to becoming a practicing physician in the United States as painless as possible.

More Free Content:

There are additional videos covering topics from Cardiology, Biostatistics, Endocrinology, Genetics, Neurology, Hematology, and more.  Be sure to subscribe to the MedSmarter Youtube channel so you don’t miss out.  The Question Break Down of the Week videos are posted every Wednesday and new content videos are posted every Tuesday and Thursday.
Our Popular Courses

Prepare to Ace Your USMLE Step 1

A Continuous Enrollment Cycle allows students more flexibility for your USMLE Step 1 Prep.

Prepare to ACE Your USMLE Step 2 CK

A Continuous Enrollment Cycle allows students more flexibility when preparing for your Step 2 CK Exam.

1:1 Personalized Tutoring Sessions

Begin with an initial consultation with a tutor to assess your strengths, weaknesses, and identify goals.

Latest Articles From Medsmarter
The Hospital Medical Hierarchy - medsmarter

The Hospital Medical Hierarchy Every Pre-Med Should Understand

Doctors medical team

How Can Foreign Medical Graduates and Doctors Practice in the US?

Skills Are Needed To Be A Doctor - medsmarter

What Skills Are Needed To Be A Doctor?

What Is the USMLE Step 1?

What Is the USMLE Step 1? Purpose, Benefits & Resources

how to become a doctor - medsmarter

7 Steps to Become a Doctor After High School

STAY CONNECTED: Signup for Email Updates

Recent Tweets

Medsmarter was a phenomenal experience. Before starting the program, I was trying to juggle several different resources and unsure how to approach studying for Step 1. Once the program started... read more

Jason Ramdat Avatar Jason Ramdat

Join the 1,000s of Students Benefitting from the MedSmarter Approach Now

Share This Story, Choose Your Platform!